cabozantinib,atezolizumab
roche
['cabo ', 'contact-03', 'rcc,(-irccs),(-srcc),(-urcc)', 'atezo']
dr. presented the results of contact-03 comparing the efficacy of cabo+atezo vs. cabo alone in clear cell mrcc that failed prior icis. atezo maintenance failed to improve the results over soc cabo. #asco23 
Medical oncologist at @BPorgbr. Former fellow of GU oncology @DanaFarber @Harvard @MOCbrasil. #GUcancer